Candriam Luxembourg S.C.A. lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 47.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 244,767 shares of the company’s stock after selling 222,225 shares during the period. Candriam Luxembourg S.C.A.’s holdings in Colgate-Palmolive were worth $16,387,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of CL. CSat Investment Advisory L.P. bought a new position in Colgate-Palmolive during the 2nd quarter worth $111,000. Bridgeworth LLC bought a new position in Colgate-Palmolive during the 2nd quarter worth $120,000. Price Capital Management Inc. bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $121,000. Fort L.P. bought a new position in shares of Colgate-Palmolive in the 2nd quarter valued at $123,000. Finally, O Brien Wealth Partners LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $123,000. Hedge funds and other institutional investors own 75.22% of the company’s stock.

Several equities analysts have recently issued reports on the company. Morgan Stanley decreased their price target on Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research note on Tuesday, October 30th. Argus decreased their price target on Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Tuesday, October 30th. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Monday, October 29th. Wells Fargo & Co decreased their price target on Colgate-Palmolive from $62.00 to $58.00 and set a “market perform” rating on the stock in a research note on Monday, October 29th. Finally, Citigroup decreased their price target on Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating on the stock in a research note on Monday, October 29th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $68.06.

In related news, CFO Henning I. Jakobsen sold 1,015 shares of the business’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total transaction of $68,055.75. Following the sale, the chief financial officer now owns 36,193 shares in the company, valued at approximately $2,426,740.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Philip G. Shotts sold 462 shares of the business’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $67.05, for a total value of $30,977.10. Following the sale, the vice president now owns 41,250 shares in the company, valued at approximately $2,765,812.50. The disclosure for this sale can be found here. Insiders own 1.02% of the company’s stock.

Shares of CL stock opened at $61.86 on Wednesday. The firm has a market cap of $53.21 billion, a P/E ratio of 20.59, a PEG ratio of 3.02 and a beta of 0.75. Colgate-Palmolive has a twelve month low of $57.41 and a twelve month high of $77.91. The company has a debt-to-equity ratio of 64.85, a quick ratio of 0.77 and a current ratio of 1.11.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.72. The business had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a return on equity of 12,004.60% and a net margin of 13.55%. Colgate-Palmolive’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.73 EPS. Equities research analysts expect that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Investors of record on Friday, October 19th will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a yield of 2.72%. Colgate-Palmolive’s dividend payout ratio is currently 58.54%.

TRADEMARK VIOLATION WARNING: “Candriam Luxembourg S.C.A. Sells 222,225 Shares of Colgate-Palmolive (CL)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.thecerbatgem.com/2018/11/14/candriam-luxembourg-s-c-a-sells-222225-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: How are the companies in the S&P 500 selected?

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.